• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 9-23 of 244 results

5 Mandatory Notice: PATENT OWNERS MANDATORY NOTICES PURSUANT TO 37...

Document IPR2019-00459, No. 5 Mandatory Notice - PATENT OWNERS MANDATORY NOTICES PURSUANT TO 37 CFR 428A2 (P.T.A.B. Jan. 11, 2019)

cite Cite Document

5 Mandatory Notice: PATENT OWNER¿¿¿S MANDATORY NOTICES PURSUANT TO...

Document IPR2019-00459, No. 5 Mandatory Notice - PATENT OWNER¿¿¿S MANDATORY NOTICES PURSUANT TO 37 CFR ¿¿ 428A2 (P.T.A.B. Jan. 11, 2019)

cite Cite Document

6 Power of Attorney: Patent Owners Power of Attorney

Document IPR2019-00459, No. 6 Power of Attorney - Patent Owners Power of Attorney (P.T.A.B. Jan. 11, 2019)

cite Cite Document

2 Power of Attorney: Petitioner, CSL Behring LLCs, Power of Attorney

Document IPR2019-00459, No. 2 Power of Attorney - Petitioner, CSL Behring LLCs, Power of Attorney (P.T.A.B. Dec. 21, 2018)

cite Cite Document

1 Power of Attorney: Petitioner, CSL Behring GmbHs, Power of Attorney

Document IPR2019-00459, No. 1 Power of Attorney - Petitioner, CSL Behring GmbHs, Power of Attorney (P.T.A.B. Dec. 21, 2018)

cite Cite Document

2001 Exhibit: Certified file history for 14855,168 Part 8 of 15

Document IPR2019-00459, No. 2001-112 Exhibit - Certified file history for 14855,168 Part 8 of 15 (P.T.A.B. Apr. 9, 2019)

cite Cite Document

2023 Exhibit: Shire Exhibit 2023 Richard J Duma et al, Parenteral Drug Administrat...

Document IPR2019-00459, No. 2023-188 Exhibit - Shire Exhibit 2023 Richard J Duma et al, Parenteral Drug Administration Routes,Precautions, Problems, Complications, and Drug Delivery Systems, (P.T...

cite Cite Document

2025 Exhibit: Shire Exhibit 2025 Tapan K Das, Protein Particulate Detection Issues...

Document IPR2019-00459, No. 2025-190 Exhibit - Shire Exhibit 2025 Tapan K Das, Protein Particulate Detection Issues inBiotherapeutics Development¿¿¿Current Status, 132 AAPSPHARMSCITECH 732 ...

cite Cite Document

2024 Exhibit: Shire Exhibit 2024 Kang Raymond C Stevens, Structural Aspects ofT...

Document IPR2019-00459, No. 2024-189 Exhibit - Shire Exhibit 2024 Kang Raymond C Stevens, Structural Aspects ofTherapeutic Enzymes to Treat Metabolic Disorders, 3012 HUMANMUTATION 1591 2...

cite Cite Document

2001 Exhibit: Certified file history for 14855,168 Part 5 of 14

Document IPR2019-00459, No. 2001-109 Exhibit - Certified file history for 14855,168 Part 5 of 14 (P.T.A.B. Apr. 9, 2019)

cite Cite Document

2001 Exhibit: Certified file history for 14855,168 Part 1 of 14

Document IPR2019-00459, No. 2001-105 Exhibit - Certified file history for 14855,168 Part 1 of 14 (P.T.A.B. Apr. 9, 2019)

cite Cite Document

2017 Exhibit: Shire Exhibit 2017 Study to Evaluate the Safety and Pharmacology o...

Document IPR2019-00459, No. 2017-182 Exhibit - Shire Exhibit 2017 Study to Evaluate the Safety and Pharmacology of SubcutaneousAdministration of CINRYZE With Recombinant Human Hyaluronidas...

cite Cite Document

2004 Exhibit: Shire Exhibit 2004 Part 4 of 37 Certified File History of US Patent No 10,080,788

Document IPR2019-00459, No. 2004-124 Exhibit - Shire Exhibit 2004 Part 4 of 37 Certified File History of US Patent No 10,080,788 (P.T.A.B. Apr. 9, 2019)

cite Cite Document

2001 Exhibit: Certified file history for 14855,168 Part 12 of 14

Document IPR2019-00459, No. 2001-116 Exhibit - Certified file history for 14855,168 Part 12 of 14 (P.T.A.B. Apr. 9, 2019)

cite Cite Document

2013 Exhibit: Shire Exhibit 2013 John F Carpenter et al, Overlooking Subvisible Pa...

Document IPR2019-00459, No. 2013-178 Exhibit - Shire Exhibit 2013 John F Carpenter et al, Overlooking Subvisible Particles inTherapeutic Protein Products Gaps that May Compromise Product Quality,...

cite Cite Document
<< 1 2 3 4 5 ... 15 16 17 >>